Compare · ORIA vs PNTM
ORIA vs PNTM
Side-by-side comparison of Orion Biotech Opportunities Corp. (ORIA) and Pontem Corporation (PNTM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ORIA and PNTM operate in Blank Checks (Finance), so they compete in similar markets.
- PNTM is the larger of the two at $838.8M, about 3.5x ORIA ($242.0M).
Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Pontem Corporation
Pontem Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest ORIA
- SEC Form SC 13G/A filed by Orion Biotech Opportunities Corp. (Amendment)
- SEC Form 4 filed by Collins James J.
- SEC Form 4 filed by Broder Samuel
- SEC Form 4 filed by Orion Sponsor Holdings, Llc
- SEC Form 4 filed by Rodriguez Louisa
- SEC Form 15-12G filed by Orion Biotech Opportunities Corp.
- SEC Form 25 filed by Orion Biotech Opportunities Corp.
- Orion Biotech Opportunities Says Will Redeem Public Share, Will Not Consummate Initial Business Combination
- Orion Biotech Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by Orion Biotech Opportunities Corp.
Latest PNTM
- SEC Form SC 13G filed by Pontem Corporation
- SEC Form SC 13G/A filed by Pontem Corporation (Amendment)
- SEC Form 15-12G filed by Pontem Corporation
- SEC Form 25-NSE filed by Pontem Corporation
- Pontem Corporation Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Redemption Price For The Public Shares Will Be ~$10.32
- Pontem Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Pontem Corporation will redeem its Public Shares and will not consummate an initial business combination
- SEC Form 10-Q filed by Pontem Corporation
- SEC Form 3 filed by new insider Hagen David
- Pontem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits